Interestingly in the Sunitinib and the combination treatments at day five post treatment while overall E-cadherin staining is lower than the control there is a re-distribution from the cell junctions to the cytoplasm and nucleus of live tumor cells (Fig. 7, Sunitinib and combination treated). Here, CDH1 is linked to neoplasm.